We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPP
976
Hudson Pacific Properties
HPP
$751M
$510K 0.02%
3,035
+2,096
+223% +$346K
PACB icon
977
Pacific Biosciences
PACB
$357M
$510K 0.02%
19,661
-130,267
-87% -$2.21M
WORK
978
DELISTED
Slack Technologies, Inc.
WORK
$510K 0.02%
12,078
+7,155
+145% +$242K
BLD
979
DELISTED
TopBuild
BLD
$509K 0.02%
2,763
-5,027
-65% -$889K
AG icon
980
First Majestic Silver
AG
$9.31B
$508K 0.02%
37,754
+14,986
+66% +$165K
BF.A icon
981
Brown-Forman Class A
BF.A
$13.1B
$507K 0.02%
6,901
+3,144
+84% +$226K
EXPO icon
982
Exponent
EXPO
$3.25B
$507K 0.02%
5,626
-24,227
-81% -$1.93M
VOOV icon
983
Vanguard S&P 500 Value ETF
VOOV
$6.75B
$507K 0.02%
4,101
+3,998
+3,882% +$468K
AVNT icon
984
Avient
AVNT
$4.16B
$506K 0.02%
12,551
-120,457
-91% -$4.25M
CRSP icon
985
CRISPR Therapeutics
CRSP
$5.17B
$506K 0.02%
3,305
+2,717
+462% +$321K
KPTI icon
986
Karyopharm Therapeutics
KPTI
$44.4M
$505K 0.02%
2,176
+1,756
+418% +$407K
HMN icon
987
Horace Mann Educators
HMN
$2.11B
$504K 0.02%
11,987
-87,433
-88% -$3.37M
AVLR
988
DELISTED
Avalara, Inc.
AVLR
$504K 0.02%
3,053
-2,607
-46% -$417K
TXG icon
989
10x Genomics
TXG
$7.42B
$502K 0.02%
3,546
+3,311
+1,409% +$480K
DOC
990
DELISTED
PHYSICIANS REALTY TRUST
DOC
$502K 0.02%
28,218
-14,848
-34% -$266K
PD icon
991
PagerDuty
PD
$919M
$501K 0.02%
12,018
+11,575
+2,613% +$395K
RDS.A
992
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$501K 0.02%
14,258
+13,856
+3,447% +$433K
SIX
993
DELISTED
Six Flags Entertainment Corp.
SIX
$500K 0.02%
14,666
-6,985
-32% -$191K
PSB
994
DELISTED
PS Business Parks, Inc.
PSB
$500K 0.02%
3,762
-8,078
-68% -$1.04M
RVTY icon
995
Revvity
RVTY
$13B
$499K 0.02%
3,481
+1,478
+74% +$197K
LBRDK icon
996
Liberty Broadband Class C
LBRDK
$5.2B
$498K 0.02%
3,144
-7,605
-71% -$1.16M
THC icon
997
Tenet Healthcare
THC
$21B
$498K 0.02%
12,459
-115,112
-90% -$3.71M
TRGP icon
998
Targa Resources
TRGP
$56.9B
$498K 0.02%
18,904
-10,451
-36% -$222K
LII icon
999
Lennox International
LII
$14.6B
$497K 0.02%
1,813
-3,683
-67% -$1.05M
NIO icon
1000
NIO
NIO
$11.9B
$497K 0.02%
10,200
+8,745
+601% +$338K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.